Share Your Insights – Global Thromboprophylaxis Practices in Cancer Care

Dear colleagues,

We invite you to participate in a global survey on thromboprophylaxis practices for patients with cancer receiving ambulatory systemic therapies. This survey aims to understand current practices, assess guideline adherence, and identify gaps in implementation of these strategies. We will also explore the role of pharmacists in optimising cancer-associated thrombosis (CAT) prevention.

Why participate?

Your expertise as a pharmacy practitioner is invaluable in shaping strategies to improve care for patients with cancer. As the questions focus on institutional policies and practices, please discuss with colleagues at your healthcare service to ensure a representative response.

The survey includes optional questions to provide identifying information about yourself, for clarification or to participate in future collaborative initiatives or research in CAT.

Time required: ~15 minutes

Survey link: https://redcap.link/yev4u00d

Deadline: 07 April 2025

This project has received low risk ethics approval by Alfred Health’s HREC to cover researchers from that site. It is also supported by the organisation [BOPA] that has agreed to distribute the survey. Please check at your site for any local ethics or research governance requirements.

Please direct any complaints relating to the conduct of this survey to the Complaints Officer, Office of Ethics and Research Governance, Alfred Health at 03 90763619 or [email protected], quote protocol number 183/25.

This important initiative has been developed in collaboration with oncology pharmacists and is supported by professional oncology organisations worldwide. Your insights will help shape future strategies to enhance evidence-based care for patients at risk of CAT.

We thank you sincerely for your time and contribution!

Regards,

Hadley Bortz ([email protected]) and A/Prof Marliese Alexander ([email protected]) Lead Investigators, on behalf of the global study team

 

Global Study Team

Australia
Hadley Bortz (Alfred Health, Victoria); A/Prof Marliese Alexander, Cheryl Jackson, Bishma Jayathilaka (Peter MacCallum Cancer Centre, Victoria); Simone Taylor (Monash Health, Victoria); Simon Huynh (Northern Health, Victoria); Dr John Coutsouvelis, Maria Larizza (Alfred Health, Victoria); Julianne Chong (Concord Hospital, New South Wales); Courtney Rose (West Moreton Health, Queensland)

Asia
Shinya Suzuki (National Cancer Centre Hospital East, Japan)

Europe
Nick Duncan (Queen Elizabeth Hospital, Birmingham, UK); Netty Cracknell (GenesisCare, UK); Tiene Bauters (Universitair Ziekenhuis Gent, Belgium)

Africa
Winnie Mwangi (Kenyatta University Teaching Referral and Research Hospital, Kenya); Eskinder Ayalew (Tikur Anbessa Specialized Hospital, Ethiopia); Kofi Boamah Mensah (Kwame Nkrumah University of Science and Technology, Komfo Anokye Teaching Hospital, Ghana)

North America
Jennifer Jupp (Alberta Health Services, Canada); Kellie Weddle (Purdue University College of Pharmacy, USA)

South America
Sara Aguayo (Hospital Base San José Osorno, Chile)

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article